Alphabet's Google and Verily Use Artificial Intelligence to Screen Patients for Diabetic Eye Conditions LatestLY

Parent company Alphabet's Google and Verily are using machine knowledge to help screen diabetic retinopathy (DR) and diabetic macular edema (DME). The two eye conditions are one of the major causes of blindness and if everything works well, it may facilitate automated screening. Which means that it will be able to detect disease sooner and provide more people with access to screenings. A part of Google's parent company Alphabet called Verily is working with Google to conduct clinical research around the world, especially in India, where studies showed the algorithm was as good at assessing images for disease as general ophthalmologists and retinal specialists, according to a blog post from the companies. Artificial Intelligence Can Detect Heart Problems in the Future, Says Study by Mayo Clinic. The "First real-world clinical use of the algorithm" has been initiated at Aravind Eye Hospital in Madurai as a result of the research.